Afatinib
About
Therapy type: Targeted therapy
Therapy strategy: EGFR inhibition
Mappings
NCI Thesaurus: Afatinib (ncit:C66940)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | EGFR somatic variants | Non-Small Cell Lung Cancer | Afatinib | FDA |
| Sensitivity (+) | EGFR somatic variants | Non-Small Cell Lung Cancer | Afatinib | HC |
| Sensitivity (+) | EGFR oncogenic variants | Non-Small Cell Lung Cancer | Afatinib | HC |